relatlimab,nivolumab
bms
['nivo', '047,(-nct047),(-0.047%)', 'relativity-047', 'relatlimab', 'nivo+rela']
it was my honor to present @ #esmo2022 a deeper look at response data by bicr $ investigator-assessed from relativity-047, orr higher for nivo+relatlimab, time to response similar &amp; median duration not reached for both arms 
#Melanoma medical oncologist and #immunotherapy & drug development investigator at @MDAndersonNews. Co-Director of the #BrainMets Clinic. Views are my own.